|
- Treatment | National Institute on Drug Abuse (NIDA)
Opioid treatment programs provide evidence-based care for opioid use disorder They may be residential or outpatient facilities They usually include treatment with medications like methadone, buprenorphine, or naltrexone, combined with behavioral therapies
- Treatment and Recovery | National Institute on Drug Abuse
Can addiction be treated successfully? Yes, addiction is a treatable disorder Research on the science of addiction and the treatment of substance use disorders has led to the development of research-based methods that help people to stop using drugs and resume productive lives, also known as being in recovery Can addiction be cured? Like treatment for other chronic diseases such as heart
- Ketamine | National Institute on Drug Abuse (NIDA)
Ketamine is a chemical compound used as an anesthetic in humans and animals 1,2 It was developed decades ago as a less toxic alternative to the drug phencyclidine (PCP), which was also developed as an anesthetic A ketamine derivative, esketamine (under the brand name Spravato ®), is approved by the U S Food and Drug Administration (FDA) for treatment-resistant depression in adults There
- Addiction Treatment - National Institute on Drug Abuse (NIDA)
Addiction Treatment In 2021, approximately 43 7 million people aged 12 or older (15 6% of the population) needed substance use treatment in the past year However, only 6 8% of them received substance use treatment at a specialty facility (2021 DT 5 39B) *1 Review these research-based guides for helpful information on addiction treatment
- Reflecting on NIDA’s 50th year and looking to 2025
This past year, NIDA commemorated its 50th anniversary, which made me reflect on how far addiction science has come in a half century—from the barest beginnings of an understanding of how drugs work in the brain, and only a few treatment and prevention tools, to a robustly developed science and multiple opportunities to translate that science into clinical practice Yet the challenges we
- Medications for Opioid Use Disorder - National Institute on Drug Abuse . . .
Information on how to get treatment for opioid use disorder from the Substance Abuse and Mental Health Services Administration (SAMHSA) How to participate in a NIDA-funded clinical trial on medications for opioid use disorder More information from SAMHSA on medications and other treatment options for substance use disorders
- Division of Epidemiology, Services and Prevention Research (DESPR)
How can we better promote evidence-based screening and treatment of HIV related to drug use? The mission of the Division of Epidemiology, Services and Prevention Research is to improve the nation's public health by promoting integrated approaches to understand and address interactions between individuals and environments
- What are treatments for tobacco dependence? - National Institute on . . .
The prevalence of tobacco use and dependence among adolescents—as well as the neurobiological impact and medical consequences of nicotine exposure—suggest that pediatric primary care settings should deliver tobacco cessation treatments to both youth and parents who use tobacco 169 Current clinical guidance does not recommend medications for adolescent tobacco cessation because of a lack
|
|
|